APA

Gastl G., Werter M., De Pauw B., Nerl C., Aulitzky W., von Lüttichau I., Tilg H., Thaler J., Lang A. & Abbrederis K. (19890706). Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients. : Leukemia.

Chicago

Gastl G, Werter M, De Pauw B, Nerl C, Aulitzky W, von Lüttichau I, Tilg H, Thaler J, Lang A and Abbrederis K. 19890706. Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients. : Leukemia.

Harvard

Gastl G., Werter M., De Pauw B., Nerl C., Aulitzky W., von Lüttichau I., Tilg H., Thaler J., Lang A. and Abbrederis K. (19890706). Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients. : Leukemia.

MLA

Gastl G, Werter M, De Pauw B, Nerl C, Aulitzky W, von Lüttichau I, Tilg H, Thaler J, Lang A and Abbrederis K. Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients. : Leukemia. 19890706.